Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias

[1]  T. Kanauchi,et al.  Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis , 2015, BMJ Open Respiratory Research.

[2]  K. Brown,et al.  Interstitial Lung Disease in Undifferentiated Forms of Connective Tissue Disease , 2015, Arthritis care & research.

[3]  T. Colby,et al.  Usual Interstitial Pneumonia Preceding Collagen Vascular Disease: A Retrospective Case Control Study of Patients Initially Diagnosed with Idiopathic Pulmonary Fibrosis , 2014, PloS one.

[4]  栄一 末松.  血管炎の新分類2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides , 2013 .

[5]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[6]  E. Miyazaki,et al.  Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. , 2013, Respiratory medicine.

[7]  Y. Kondoh,et al.  Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients. , 2012, Respiratory medicine.

[8]  P. Ind,et al.  Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. , 2011, Rheumatology.

[9]  I. Noth,et al.  Autoimmune-featured interstitial lung disease: a distinct entity. , 2011, Chest.

[10]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[11]  T. Colby,et al.  Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). , 2010, Respiratory medicine.

[12]  S. West,et al.  Connective tissue disease-associated interstitial lung disease: a call for clarification. , 2010, Chest.

[13]  H. Collard,et al.  Undifferentiated Connective Tissue Disease-Associated Interstitial Lung Disease: Changes in Lung Function , 2010, Lung.

[14]  M. Kokosi,et al.  Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis , 2009, European Respiratory Journal.

[15]  Kazuo Suzuki,et al.  A Comparison of the Clinical Features of ANCA-Positive and ANCA-Negative Idiopathic Pulmonary Fibrosis Patients , 2008, Respiration.

[16]  Z. Amoura,et al.  Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature , 2008, Annals of the rheumatic diseases.

[17]  V. Cottin,et al.  ANCA-associated lung fibrosis: analysis of 17 patients. , 2008, Respiratory medicine.

[18]  N. Müller,et al.  Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.

[19]  H. Collard,et al.  Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? , 2007, American journal of respiratory and critical care medicine.

[20]  A. Nicholson,et al.  Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. , 2007, American journal of respiratory and critical care medicine.

[21]  D. Scott,et al.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies , 2006, Annals of the rheumatic diseases.

[22]  F. Quismorio,et al.  Pulmonary involvement in microscopic polyangiitis , 2005, Current opinion in pulmonary medicine.

[23]  K. Nakata,et al.  Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody‐associated vasculitides , 2004, Respirology.

[24]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[25]  J Stebbing,et al.  Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. , 2000, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[26]  F. Askin,et al.  The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. , 1995, American journal of clinical pathology.

[27]  R. Porter.  Nomenclature of Systemic Vasculitides: Proposal of an International Consensus Conference , 1995 .

[28]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[29]  G. Hoffman,et al.  Antineutrophil cytoplasmic antibodies. , 1998, Arthritis and rheumatism.